User journeys in cross-European secondary use of health data: insights ahead of the European Health Data Space
The European Health Data Space (EHDS) regulation aims to facilitate cross-border sharing of health data across Europe. However, practical challenges related to data access, interoperability, quality, and interpretive competence remain, particularly when working with health systems across countries. This study aimed to evaluate and report the user journey of researchers accessing and utilizing health data across four European countries for secondary research purposes prior to implementation of EHDS. We conducted a narrative reflection of individual and collective experiences on key aspects of the user journey-discovery, access, use, and finalization. Data were gathered from various structured and unstructured sources, including an online log, prospective questionnaires, regular meetings, and interviews. Researchers faced challenges at different steps of the user journey, which included lack of data quality in national metadata catalogues (discovery stage). Differences in national regulations led to inconsistent timelines for gaining access to data (access stage), with approval times ranging from a few months to over a year. At the use stage, researchers experienced challenges in harmonizing health data due to variations in coding practices and data quality. Issues related to computational capacity caused further delays. Substantial challenges must be addressed for EHDS to succeed. Establishing knowledge hubs, fostering collaborations, and streamlining access processes are essential. Close collaboration with experts will likely be essential for an effective user journey. This analysis underscores the importance of collaboration, analytical reproducibility, and clear documentation to ensure the success and timely delivery of cross-border projects.
Authors
- Anna‐Leena Vuorinen (ORCID: https://orcid.org/0000-0002-5658-1305)
- Petr Holub (ORCID: https://orcid.org/0000-0002-5358-616X)
- Gayo Diallo (ORCID: https://orcid.org/0000-0002-9799-9484)
- Klaus Hoeyer (ORCID: https://orcid.org/0000-0002-2780-4784)
- Eva G. Álvarez (ORCID: https://orcid.org/0000-0002-3522-5088)
- Enrique Bernal‐Delgado (ORCID: https://orcid.org/0000-0002-0961-3298)
- Francisco Estupiñán‐Romero (ORCID: https://orcid.org/0000-0002-6285-8120)
- Rachel Forster (ORCID: https://orcid.org/0000-0002-7952-3570)
- Adrian G. Zucco (ORCID: https://orcid.org/0000-0002-9827-1559)
- Naja Hulvej Rod (ORCID: https://orcid.org/0000-0002-6400-5105)
- Tibor V. Varga (ORCID: https://orcid.org/0000-0002-2383-699X)
- Anil Rawat (ORCID: https://orcid.org/0000-0001-9877-9283)
- Madeleine Gorman-Asal
- Andrea Ganna
- Christina Hilmarsen
Institutions
- University of New Brunswick (CA)
- Broad Institute (US)
- University of Copenhagen (DK)
- Norwegian Institute of Public Health (NO)
- University of Helsinki (FI)
- Université de Bordeaux (FR)
- Inserm (FR)
- Tampere University (FI)
- Masaryk University (CZ)
- Massachusetts General Hospital (US)
- University College Copenhagen (DK)
- Biobanking and Biomolecular Resources Research Infrastructure Consortium (AT)
- Bordeaux Population Health (FR)
- Institute for Molecular Medicine Finland (FI)
- Instituto de Investigación Sanitaria Aragón (ES)
- Czech Academy of Sciences, Institute of Computer Science (CZ)
Publication Details
- Journal
- European Journal of Public Health
- Published
- 2025-06-05
- DOI
- https://doi.org/10.1093/eurpub/ckaf096
- Citations
- 1
- Primary Topic
- Chronic Disease Management Strategies
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- European Commission
- Novo Nordisk
- TrygFonden
- Novo Nordisk Fonden
- Helsedirektoratet
- Terveyden ja hyvinvoinnin laitos
- Norwegian Institute of Public Health